Unknown

Dataset Information

0

DNA methylation signatures of illicit drug injection and hepatitis C are associated with HIV frailty.


ABSTRACT: Intravenous illicit drug use (IDU) and hepatitis C infection (HCV) commonly co-occur among HIV-infected individuals. These co-occurring conditions may produce interacting epigenetic effects in white blood cells that influence immune function and health outcomes. Here, we report an epigenome-wide association analysis comparing IDU+/ HCV+ and IDU-/HCV- in 386 HIV-infected individuals as a discovery sample and in 412 individuals as a replication sample. We observe 6 significant CpGs in the promoters of 4 genes, NLRC5, TRIM69, CX3CR1, and BCL9, in the discovery sample and in meta-analysis. We identify 19 differentially methylated regions on chromosome 6 harboring MHC gene clusters. Importantly, a panel of IDU+/HCV+-associated CpGs discriminated HIV frailty based upon a validated index with an area under the curve of 79.3% for high frailty and 82.3% for low frailty. These findings suggest that IDU and HCV involve epigenetic programming and that their associated methylation signatures discriminate HIV pathophysiologic frailty.

SUBMITTER: Zhang X 

PROVIDER: S-EPMC5740109 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

DNA methylation signatures of illicit drug injection and hepatitis C are associated with HIV frailty.

Zhang Xinyu X   Hu Ying Y   Justice Amy C AC   Li Boyang B   Wang Zuoheng Z   Zhao Hongyu H   Krystal John H JH   Xu Ke K  

Nature communications 20171221 1


Intravenous illicit drug use (IDU) and hepatitis C infection (HCV) commonly co-occur among HIV-infected individuals. These co-occurring conditions may produce interacting epigenetic effects in white blood cells that influence immune function and health outcomes. Here, we report an epigenome-wide association analysis comparing IDU+/ HCV+ and IDU-/HCV- in 386 HIV-infected individuals as a discovery sample and in 412 individuals as a replication sample. We observe 6 significant CpGs in the promoter  ...[more]

Similar Datasets

2017-11-17 | GSE107080 | GEO
2017-11-17 | GSE107082 | GEO
2017-11-17 | GSE100264 | GEO
| PRJNA418969 | ENA
| PRJNA418964 | ENA
| S-EPMC2857281 | biostudies-literature
| S-EPMC3561408 | biostudies-literature
| S-EPMC6293604 | biostudies-literature
| S-EPMC4643614 | biostudies-literature
| S-EPMC11258465 | biostudies-literature